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Abstract
In order to be optimally effective, continuing training programmes for health-care professionals
need to be tailored so that they target specific knowledge deficits, both in terms of topic content
and appropriate intervention strategies. A first step in designing tailored treatment programmes is
to identify the characteristics of the relevant health-care professional group, their current levels of
content and treatment knowledge, the estimated prevalence of drug and alcohol problems among
their patients and their preferred options for receiving continuing education and training. This study
reports the results of a survey of 53 primary care physicians working in Iran. The majority were
male, had a mean age of 44 years and saw approximately 94 patients per week. In terms of their
patients' drug use, primary care physicians thought most patients with a substance use problem
were male, women were most likely to use tobacco (52%), opium (32%) and marijuana/hashish and
young people were most likely to use tobacco, alcohol, marijuana and heroin. Counselling and
nicotine patches were the treatments most commonly provided. Although the majority (55%)
reported referring patients to other services, more than a third did not. Most primary care
physicians reported being interested in attending further training on substance abuse issues. The
implications of these data for ongoing education and training of primary care physicians in Iran are
discussed.
Background
The collection and interpretation of accurate descriptive
data is an essential step in ultimately reducing the burden
of harm associated with substance use [1,2]. Traditionally,
these data have been sought to identify the characteristics
of at-risk individuals or groups, quantify the size of the
problem (incidence and prevalence) and, when repeated
on the same population and using the same measures,
monitor trends over time and assess the effects of inter-
ventions. More recently, these same principles have been
applied to health care providers, as a mechanism for
improving their quality of care [3]. As for at-risk individu-
als, accurate descriptive data identify the characteristics of
health care providers and their knowledge gaps, and
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facilitate quality assurance monitoring of their practice
over time.
Descriptive data also help optimise the cost-effectiveness
of interventions in two ways. Firstly, at an individual level,
they enable greater accuracy in tailoring interventions and
treatment goals to specific problem behaviours [4]. Sec-
ondly, at a systems level, they provide an empirical ration-
ale for the equitable distribution of intervention
resources, a notion espoused by the World Health Organ-
isation (WHO) as a key principle of accessibility to pri-
mary health care, in which core services available to all are
complemented by interventions targeting those at
increased risk [5].
As is typically the case internationally, the centrality of pri-
mary care in Iran is reflected in its role as the usual first
point of contact with the formal health-care system. It is
the principal juncture at which a range of health services
can be mobilised and co-ordinated in order to manage
complex health problems, such as substance abuse.
In assessing the potential to improve the quality and
equity of primary health care for substance abuse prob-
lems in Iran, an initial step is to determine the character-
istics of primary care practitioners, including their
knowledge and perceptions of substance use, as well as
identify their requirements for on-going education and
training.
Therefore, this study has three aims. Firstly, to describe the
demographic and practice characteristics of a sample of
General Practitioners (GPs) working in Iran. Secondly, to
identify their perceptions of substance use among their
patients and their current practice regarding treatment.
Thirdly, to identify Iranian GPs' interest in on-going edu-
cation and training, their knowledge gaps and their pref-
erences for the format of such training.
Method
Sample
GPs attending one of two mandatory training workshops
in Tehran, Iran, were asked to complete a written ques-
tionnaire. Both workshops were held in the winter of
2003 and were attended by 50 GPs each. The topic of one
workshop was an examination of psychiatry and medicine
and the other focused on surgery. GPs throughout Iran
travel to Tehran to attend these workshops, because they
require ongoing accreditation to renew their licence to
practice.
Measures
The pen-and-paper questionnaire was devised in English
and translated into Farsi. Specific questions were asked in
a number of domains, covering primary care practitioners'
demographic and practice characteristics, and their per-
ceptions of: substance use among their patients; substance
use treatment characteristics; their current practice in
regard to treatment for substance use; and their on-going
training and education preferences. The full survey is
available at the PIRT website http://
ndarc.med.unsw.edu.au/ndarc.nsf/website/Research.pirt.
Procedure
The questionnaire items were devised in conjunction with
an Iranian GP (BN), who also distributed the question-
naires at the GP workshops. The completed question-
naires were photocopied and couriered to the research
centre in Sydney, Australia. GPs' responses were translated
back from Farsi to English, entered into an Excel spread-
sheet and transferred to SPSS for Windows, Version 12, for
analyses. Descriptive statistics report means, percentages
and ranges as appropriate.
Results
Sample
Of the 100 GPs who attended one of the workshops, 53
completed the questionnaire.
GP demographic and practice characteristics
The majority of GPs were male (84%) with a mean age of
44 years (range 26 to 74 years). Their year of graduation
from medical school ranged from 1950 to 2001 and the
mean number of years practicing as a primary care physi-
cian was 16. The estimated mean number of patients seen
per week was 94, of whom an estimated mean of 12 were
substance users. Thirty eight percent of GPs reported see-
ing more than five substance using patients per week,
while 2% said they have no substance using patients. GPs
visited an estimated mean of 15 substance users per week,
as opposed to seeing them in their primary care practice.
GPs' perceptions of substance use characteristics of their 
patients
Table 1 reports GPs' perceptions of substance use charac-
teristics among their patients.
Most GPs viewed substance use problems as a psycholog-
ical issue (82%) and that most patients with a substance
use problem are male (81%). A substantial percentage of
GPs reported moderate (54%) or high (27%) awareness
of substance abuse issues. Some GPs thought emotional
(49%) or social (45%) factors were the cause of addiction.
Almost all GPs (94%) thought drug addiction trends in
Iran have increased in the previous five years and a com-
parable percentage thought the increase had been greater
for females (42%) compared to males (38%). The most
commonly cited reasons for increased drug addiction
were social or family issues (n = 22), followed by eco-
nomic factors (n = 20).International Journal for Equity in Health 2005, 4:7 http://www.equityhealthj.com/content/4/1/7
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GPs' perceptions of substance use characteristics by sex 
and age
The majority of GPs perceived that women were most
likely to use tobacco (52%), opium (32%), marijuana/
hashish (32%) and heroin (14%). The majority of GPs
thought young people (aged less than 25 years) were will-
ing to use tobacco (97%), alcohol (63%), marijuana
(56%) and heroin (53%), but were relatively unlikely to
use black water (the dissolved residue from an opium
pipe) (7%) and barbiturates (7%). The majority of GPs
thought people aged 25 to 44 years were willing to use
opium (84%), alcohol (61%) and heroin (52%), while
those aged at least 45 years, were most willing to use
opium (60%), followed by black water (28%) and alco-
hol (22%).
GPs' perceptions of patient and treatment characteristics 
associated with interventions for substance use
Table 2 reports GPs' perceptions of patient and treatment
characteristics associated with interventions for substance
use.
The majority of GPs thought males were more willing to
quit substance use (62%) and that those aged 25 years or
less were the most appropriate group at which to target
campaigns against substance misuse (68%). The majority
of GPs thought family or marital pressure was the main
motive for quitting substance use (60%), followed by eco-
nomic pressure (44%), being tired of addiction (42%)
and legal problems (22%). The most commonly cited
suitable substitute for drug use was some type of treat-
ment (n = 18). With regard to nicotine, the most com-
monly cited effective method for quitting use was
counselling or psycho-social intervention (n = 22), while
the most commonly cited important side-effect was rest-
lessness or irritability (n = 18) and relatively few (n = 6)
regarded complementary approaches, such as hypno-
therapy and chiropractic therapy, as effective. The major-
ity of GPs (71%) thought primary care was a suitable
setting for delivery of services to patients with substance
use problems.
GPs' current practice in regard to treatment for substance 
misuse
Table 3 reports GPs' current practice.
The majority of GPs reported that they did not conduct
diagnostic physiological assessments (75%) and that they
did not prescribe medications for detoxification (61%).
The most commonly provided treatments reported were
counselling or psychotherapy (n = 20), followed by nico-
tine patches (n = 11). The most commonly provided
relapse information was to avoid or reduce contact with
other drug users (n = 8). The majority of GPs said that they
referred patients to a social worker or detoxification unit
(55%), while a substantial percentage reported not refer-
ring at all (39%).
Table 1: GPs' perceptions of substance use characteristics of 
their patients (N = 53)
Characteristica % or n
Of your patients who have drug problems, what % are:
Male 81%
What is the cause of addiction?b
Emotional 49%
Social 45%
Family 35%
Economic 31%
Leisure 31%
Wrong role models 26%
In the last 5 years, have drug addiction trends increased, 
decreased, unchanged:
Increased 94%
In the last 5 years, drug abuse increased more for males or 
femalesc:
Females 42%
Males 38%
Same 18%
If increased, why?d
Social/family issues 22
Economic reasons 20
Unemployment 17
Easy access to drugs 17
Lack of recreation/sport facilities 10
Youth-related issues 9
Ineffective law enforcement/government action 6
Inadequate education 2
Other 10
What is your view of drug addicts?b
Psychologically ill 82%
Physically ill 22%
Burden on society 22%
Criminals 2%
Level of awareness about substance abusee
Moderate 54%
High 27%
aData missing: n = 2–5
bDoes not sum to 100%, because some GPs gave more than one 
answer and some gave no answer
cDon't know = 2%
dDoes not sum to 53, because some GPs gave more than one answer 
and same gave no answer
eAwareness rated on Likert scale from 1 (very unaware) – 10 (very 
aware): low = 1–3; moderate = 4–8; high = 8–10International Journal for Equity in Health 2005, 4:7 http://www.equityhealthj.com/content/4/1/7
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GPs' on-going training and education preferences
The majority of GPs reported that they were interested in
attending seminars and further training related to sub-
stance abuse issues (89%) and the most preferred format
for such training was two days over a two week period
(54%), followed by two days in one week (25%) and two
consecutive days (13%). Six per cent reported no
preference.
Discussion
The potential to improve the quality and equity of pri-
mary health care for substance abuse problems in Iran, is
clearly evidenced by the low proportion of GPs (27%)
who currently rate their level of awareness of substance
abuse issues as high, despite having been practicing as GPs
for a mean of 16 years. This apparent lack of knowledge
and skills regarding substance abuse issues is consistent
with views of GPs in Western countries [6,7]. The appro-
priateness of on-going education and training workshops
as a mechanism to realise this potential for improvement
is reflected by the high proportion of GPs (89%) who
indicated an interest in attending such seminars.
The results of this survey also identify potential topics for
these workshops that are most likely to maximise their
impact. That a minority of GPs (22%) consider patients
with substance use problems as being physically ill (Table
1) and do not regard physical illness as an important
motive for quitting substance use (4%), suggests a teach-
ing focus on the development of physiological depend-
ence following initiation to drug use would improve GPs'
understanding of the nature and impact of physiological
dependence. In turn, this may encourage the high propor-
tion of GPs who do not currently prescribe medication for
detoxification (61%) or conduct physiological assess-
ments (75%), to review their practice (Table 3).
Similarly, a greater number of GPs may be more inclined
to discuss problems associated with relapse to drug use,
complemented by monitored pharmacotherapy, or on-
going counselling (Table 3). Although a lack of resources
may help explain a reluctance to prescribe medication and
conduct physiological assessments, GP training could
emphasise the need to address issues around physical
dependence, as well as the social/familial/economic
impacts, along with basic physiological tests that could be
conducted periodically. GPs would likely find this
approach acceptable, given some cited drug substitution
as a suitable treatment and reported currently prescribing
nicotine patches (Table 3). Such a change in Iranian GPs'
practice would also appropriately reflect the apparent
improved rates of quitting smoking, compared to mono-
therapy or unassisted attempts to quit, in the interna-
tional literature [8-11].
Table 2: GPs' perceptions of patient and treatment 
characteristics associated with interventions for substance use 
(N = 53)
Characteristica % or n
Who is more willing to quit?
Males 62%
Don't know 11%
Target groups for campaigns against abuse?
Youth ≤  25 years 68%
Urban 5%
Users and drug and alcohol organisations 8%
Jails 3%
Other 16%
What is the most important motive for quitting?b
Family or marital pressure 60%
Economic pressure 44%
Tired of addiction 42%
Legal issues 22%
Employment issues 12%
Physical illness 4%
Other 4%
What is a suitable substitute for substance use?c
Drug or other treatment 18
Societal, family or community factors 16
Recreational/sporting activities 11
Employment 10
Restricted access or punitive (eg. jail) 3
Nothing or don't know 7
Most effective methods for quitting nicotine?c
Counselling or psycho-social interventions 22
Recreational or sporting activities 9
Pharmacotherapy 7
Combination of therapies 3
Alternative therapies 1
Individual's determination to quit 2
Don't know 3
Important side-effects of quitting nicotine?c
Restlessness/irritability 18
Physical symptoms/effects 13
Emotional symptoms/effects 7
Non-specified withdrawal symptoms 4
None 7
Effectiveness of complementary medicines for nicotine dependence?c
Not effective/minimal 10
Somewhat effective 12
Effective 6
Other 6
Don't know 12
Suitability of GP to provide drug services
Suitable 71%
aData missing: n = 3–12
bDoes not sum to 100%, because these questions asked separately
cDoes not sum to 53, because some GPs gave more than one answer 
and some gave no answerInternational Journal for Equity in Health 2005, 4:7 http://www.equityhealthj.com/content/4/1/7
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GPs are clearly aware of the importance of prevention, as
evidenced by two-thirds thinking that campaigns against
drug abuse would most effectively target young people,
presumably prior to the onset of significant dependence.
This suggests GPs would be prepared to become involved
in preventive activities, in addition to their more tradi-
tional role of providing treatment. Therefore, training pro-
grammes might also usefully provide GPs with resources
and ideas that they can implement to facilitate effective
prevention. For example, cost-effective GP prevention
efforts would target defined groups with high prevalence
rates of use for particular substances: young people aged
less than 25 years could be targeted with programs aimed
at minimising harm associated with smoking, alcohol and
marijuana use, given the majority of GPs perceive that
young people are relatively willing to use tobacco (97%),
alcohol (63%) and marijuana or hashish (56%). A partic-
ular area of concern, given disproportionately greater
probability of substantial negative social and health out-
comes, is that 53% of GPs perceive young people are will-
ing to use heroin.
Another example may be the apparent importance of tar-
geting womens' use of tobacco, opium and marijuana or
hashish, given 52%, 32% and 32% of GPs' respectively,
perceive that these are the substances most likely to be
used by women. As such, GPs' consultations with their
female patients could emphasise the importance of not
smoking any substances to reduce the possibility of dele-
terious health outcomes.
In addition to the potential to improve the quality and
equity of primary health care for substance abuse prob-
lems in Iran at the GP level, there also appear to be oppor-
tunities at the administrative level. For example, there
may be value in the Health Department exploring oppor-
tunities for formalising referral networks, in order to
achieve clarity around pathways from primary care set-
tings to more specialist clinical settings, given only about
one-third of GPs (39%) report referring to social workers
or detoxification units. There may also be scope to make
pharmacotherapies of demonstrated cost-effectiveness
more readily available to GPs to prescribe, along with
greater access to relevant physiological tests. Clearly, the
feasibility of these options needs to be considered within
the context of the Iranian health care system.
The generalisability of these results to the population of
primary care practitioners in Iran is likely to be limited by
two main factors. Firstly, only a small proportion of GPs
in Iran participated in this study. However, an attempt
was made to minimise this limitation by ensuring that the
workshops from which these practitioners were recruited
was unrelated to substance use and, as such, the views of
these practitioners are likely to represent typical levels of
interest and knowledge in drug- and alcohol-related
issues. The likelihood that these GPs are typical of Iranian
GPs is further indicated by the mandatory nature of the
workshops: that they are compulsory for ongoing profes-
sional accreditation in Iran decreases the possibility that
workshops are only attended by a self-selected sub-group
of GPs.
Secondly, since only 53% of those who attended a work-
shop completed a questionnaire, it may be that those with
an interest in the drug and alcohol field, or those who see
a relatively large proportion of patients with substance
misuse problems, were more likely to complete the sur-
vey. The implication of that scenario is that these results
are likely to represent a bias towards GPs with greater
Table 3: GPs' current practice in regard to treatment for 
substance misuse (N = 53)
Current treatment practicesa % or n
I conduct diagnostic physiological assessments
No 75%
Blood, heart, lung test 18%
Blood test only 4%
Spirometry 4%
I prescribe medications for detoxification
No 61%
Treatments I commonly use areb:
Counselling or psychotherapy 20
Nicotine patch 11
Non-specified medication 8
Personal/family responsibility 4
Alternative therapy 3
Other 7
Don't know 4
I provide the following relapse informationb:
Avoid or reduce contact with drug users 8
Psychological/personal determination factors most 
important
7
Family/friends/social support important 6
Recommend counselling or pharmacotherapy 6
No relapse problems 2
Don't know 2
Other 10
I refer to social workers or detoxification units
No 39%
Yes, some patients 43%
Yes, all patients 7%
Yes, if patient is willing 5%
Not applicable 7%
aData missing: n = 7–25
bDoes not sum to 53, because some GPs gave more than one answer 
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knowledge or experience in providing health care services
to patients with drug and alcohol problems, in which case
identified knowledge deficits and training needs would
actually be greater among the general population of GPs
in Iran.
Future international collaborative research efforts could
be improved in a number of ways. Firstly, the process of
translation and back translation is susceptible to error and
is difficult to monitor accurately. A possible method of
reducing translation errors could be to employ translators
with substantive knowledge in the drug and alcohol field.
Secondly, working with one local researcher to apply a
standardised and agreed protocol for distributing the sur-
vey, would minimise the possibility of bias resulting from
different people administering the survey in different
ways. Thirdly, clarity regarding definitions of key terms
during the development of survey items and protocols is
crucial. Using the example of this study, terms such as
'drug addict' and 'complementary medicine' should be
clearly defined.
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